Arrhenius T - Search Results

1

The conformational restriction of synthetic vaccines for malaria.

Satterthwait AC, Chiang LC, Arrhenius T, Cabezas E, Zavala F, Dyson HJ, Wright PE, Lerner RA. Satterthwait AC, et al. Among authors: arrhenius t. Bull World Health Organ. 1990;68 Suppl(Suppl):17-25. Bull World Health Organ. 1990. PMID: 2094582 Free PMC article. Review.

2

The conformational restriction of synthetic peptides, including a malaria peptide, for use as immunogens.

Satterthwait AC, Arrhenius T, Hagopian RA, Zavala F, Nussenzweig V, Lerner RA. Satterthwait AC, et al. Among authors: arrhenius t. Philos Trans R Soc Lond B Biol Sci. 1989 Jun 12;323(1217):565-72. doi: 10.1098/rstb.1989.0036. Philos Trans R Soc Lond B Biol Sci. 1989. PMID: 2569211

3

Conformational restriction of peptidyl immunogens with covalent replacements for the hydrogen bond.

Satterthwait AC, Arrhenius T, Hagopian RA, Zavala F, Nussenzweig V, Lerner RA. Satterthwait AC, et al. Among authors: arrhenius t. Vaccine. 1988 Apr;6(2):99-103. doi: 10.1016/s0264-410x(88)80007-0. Vaccine. 1988. PMID: 3291460 Review.

4

Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo.

del Guercio MF, Alexander J, Kubo RT, Arrhenius T, Maewal A, Appella E, Hoffman SL, Jones T, Valmori D, Sakaguchi K, Grey HM, Sette A. del Guercio MF, et al. Among authors: arrhenius t. Vaccine. 1997 Mar;15(4):441-8. doi: 10.1016/s0264-410x(97)00186-2. Vaccine. 1997. PMID: 9141216

5

Archean geochemistry of formaldehyde and cyanide and the oligomerization of cyanohydrin.

Arrhenius T, Arrhenius G, Paplawsky W. Arrhenius T, et al. Among authors: arrhenius g. Orig Life Evol Biosph. 1994 Feb;24(1):1-17. doi: 10.1007/BF01582036. Orig Life Evol Biosph. 1994. PMID: 11536656

6

HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions.

Sette A, Sidney J, Oseroff C, del Guercio MF, Southwood S, Arrhenius T, Powell MF, Colón SM, Gaeta FC, Grey HM. Sette A, et al. Among authors: arrhenius t. J Immunol. 1993 Sep 15;151(6):3163-70. J Immunol. 1993. PMID: 7690794

7

Lipopeptide particles as the immunologically active component of CTL inducing vaccines.

Tsunoda I, Sette A, Fujinami RS, Oseroff C, Ruppert J, Dahlberg C, Southwood S, Arrhenius T, Kuang LQ, Kubo RT, Chesnut RW, Ishioka GY. Tsunoda I, et al. Among authors: arrhenius t. Vaccine. 1999 Feb 26;17(7-8):675-85. doi: 10.1016/s0264-410x(98)00250-3. Vaccine. 1999. PMID: 10067673

8

On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs.

O'Sullivan D, Arrhenius T, Sidney J, Del Guercio MF, Albertson M, Wall M, Oseroff C, Southwood S, Colón SM, Gaeta FC, et al. O'Sullivan D, et al. Among authors: arrhenius t. J Immunol. 1991 Oct 15;147(8):2663-9. J Immunol. 1991. PMID: 1717570

9

T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis.

Franco A, Southwood S, Arrhenius T, Kuchroo VK, Grey HM, Sette A, Ishioka GY. Franco A, et al. Among authors: arrhenius t. Eur J Immunol. 1994 Apr;24(4):940-6. doi: 10.1002/eji.1830240424. Eur J Immunol. 1994. PMID: 7512036

10

High affinity for class II molecules as a necessary but not sufficient characteristic of encephalitogenic determinants.

Wall M, Southwood S, Sidney J, Oseroff C, del Guericio MF, Lamont AG, Colón SM, Arrhenius T, Gaeta FC, Sette A. Wall M, et al. Among authors: arrhenius t. Int Immunol. 1992 Jul;4(7):773-7. doi: 10.1093/intimm/4.7.773. Int Immunol. 1992. PMID: 1379827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters